APA (7th ed.) Citation

Bodei, L., Kidd, M., Modlin, I., Severi, S., Drozdov, I., Nicolini, S., . . . Paganelli, G. (2016). Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors. European Journal of Nuclear Medicine & Molecular Imaging, 43(5), 839. https://doi.org/10.1007/s00259-015-3250-z

Chicago Style (17th ed.) Citation

Bodei, L., et al. "Measurement of Circulating Transcripts and Gene Cluster Analysis Predicts and Defines Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors." European Journal of Nuclear Medicine & Molecular Imaging 43, no. 5 (2016): 839. https://doi.org/10.1007/s00259-015-3250-z.

MLA (9th ed.) Citation

Bodei, L., et al. "Measurement of Circulating Transcripts and Gene Cluster Analysis Predicts and Defines Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors." European Journal of Nuclear Medicine & Molecular Imaging, vol. 43, no. 5, 2016, p. 839, https://doi.org/10.1007/s00259-015-3250-z.